25 results
Plasmacytomas and Plasma-Cell Leukemia - Physical examination revealed multiple exophytic subcutaneous lesions involving the arms and
Plasmacytomas and Plasma-Cell ... revealed 25% plasma cells ... stain) #Clinical #HONC ... Leukemia #Smear #NEJM
Signaling Mechanism of PD-1 and PD-L1 and Inhibition of PD-1 Signaling in Microsatellite-Instability–High Cancers. MHC1 denotes
Microsatellite-Instability–High Cancers ... histocompatibility complex 1 #Pathophysiology ... #Honc #Pharm #PD1 ... MicrosatelliteInstability #NEJM
Activated T-Cell Killing a Cancer Cell

#TCell #Killing #Cancer #Cells #clinical #microscopy #video
Activated T-Cell ... Killing a Cancer ... Cell #TCell #Killing ... #Cancer #Cells ... #clinical #microscopy
Activated T-Cell Killing a Cancer Cell

#TCell #Killing #Cancer #Cells #clinical #microscopy #video
Activated T-Cell ... Killing a Cancer ... #Killing #Cancer ... #Cells #clinical ... #microscopy #video
Hemolysis in Hereditary Spherocytosis. Panel A shows the structure of a normal red cell and a
spleen in which red cells ... between endothelial cells ... #Pathophysiology ... #Honc #IM #Spherocytosis ... HereditarySpherocytosis #NEJM
Nephron Remodeling as a Mechanism of Diuretic Resistance. When high doses of loop diuretics are used
convoluted tubule cells ... , principal cells ... and intercalated cells ... #Pathophysiology ... NephronRemodeling #NEJM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
ALK-Positive Non–Small-Cell ... Lung Cancer #EBM ... #Honc #Alectinib ... VisualAbstract #NEJM
Pathogenesis of meningitis 

Risk factors for pathogen entry include immunocompromised state (HIV positive, cancer, chemotherapy patients,
(HIV positive, cancer ... Immune cells and ... endothelial cells ... endothelial cells ... as the nearby cells
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
antigen-presenting cell ... of activated T cells ... #Pathophysiology ... #IM #Honc #Pharm ... Immunosuppression #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
III Non–Small-Cell ... Lung Cancer - Progression-free ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM